The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 08, 2025

Filed:

Jun. 30, 2022
Applicant:

Leidos, Inc., Reston, VA (US);

Inventors:

Gabriel M. Gutierrez, Reston, VA (US);

Vinayaka Kotraiah, Reston, VA (US);

Timothy W. Phares, Reston, VA (US);

James Pannucci, Reston, VA (US);

Marc Mansour, Reston, VA (US);

Assignee:

Leidos, Inc., Reston, VA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 7/08 (2006.01); A61K 38/04 (2006.01); A61K 38/10 (2006.01); A61K 38/16 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); C07K 14/00 (2006.01); C07K 16/28 (2006.01); C12N 15/11 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2803 (2013.01); A61K 38/04 (2013.01); A61K 38/10 (2013.01); A61K 38/16 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); C07K 7/08 (2013.01); C07K 14/00 (2013.01); C12N 15/11 (2013.01); C12N 2310/315 (2013.01); C12N 2310/321 (2013.01);
Abstract

This disclosure provides nucleic acids encoding peptides which bind to LAG3 and can be used to block the interaction of LAG 3 with other molecules such as MHC-II, FGL1, and α-synuclein. These peptides can be used for various therapeutic purposes, such as inhibiting the progression of a hyperproliferative disorder, including cancer, or inhibiting the progression of a synucleinopathy, inhibiting the progression of sepsis, inhibiting the progression of an infectious disease, and enhancing a response to a vaccine.


Find Patent Forward Citations

Loading…